Results 271 to 280 of about 292,750 (306)

Cell-Mediated Immunity in Tumor Rejection

1982
It is now almost axiomatic that host immune reactivity is an important factor in resistance to tumors, regardless of the tumor initiating agent or event. Although much effort was initially expended concerning humoral immune mechanism in malignancy, many studies over the last decade or so have focused attention mainly on cell-mediated immune (CMI ...
Steven Specter, Herman Friedman
openaire   +1 more source

Immunity of Allograft Rejection: An Overview

2004
Transplantation between genetically disparate individuals of the same species evokes numerous changes in the host and the graft. In general, the outcome of a transplanted organ is determined by two closely interrelated components. The first component is the biology of the foreign graft (i.e., type of organ and its macro-and microenvironments, the ...
Worakij Chalermskulrat, Isabel R Neuringer, Robert M. Aris   +2 more
openaire   +1 more source

Tumor Rejection Antigens and Immune Surveillance

1992
The existence of specific tumor rejection antigens was first demonstrated with chemically induced mouse sarcomas: each tumor was found to express a different antigen [1]. Similar findings were made with ultraviolet-induced tumors [2]. Later, the generality of the existence of tumor rejection antigens was questioned when spontaneous mouse tumors were ...
B. Van den Eynde, B. Lethé, A. Van Pel, T. Boon   +3 more
openaire   +1 more source

IMMUNE MECHANISMS IN ORGAN ALLOGRAFT REJECTION

Transplantation, 1983
R P, Lowry, K E, Gurley, R D, Forbes
openaire   +3 more sources

Cellular immune reaction in hyperacute rejection

Transplantation Proceedings, 1998
S, Wada, H, Ochikubo, Y, Sugawara, T, Sueda, K, Fujii, H, Kajihara, Y, Matsuura   +6 more
openaire   +2 more sources

Tumour rejection in immunized guinea-pigs.

British journal of experimental pathology, 1984
The morphological aspect of the antineoplastic defence mechanism was studied in Sewall-Wright strain 13 guinea pigs using isogeneic line 2 hepatoma cells. When these tumour cells were injected i.p. into isogeneic hosts, they grew rapidly and always killed their hosts within 8 weeks.
A, Kolin, J, Vacek, S, Landi
openaire   +1 more source

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Immune rejection

2013
Paul J. Martin, Robert B. Levy
openaire   +1 more source

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Philip E Castle, Vikrant V Sahasrabuddhe
exaly  

IMMUNE RESPONSES AND ALLOGRAFT REJECTION

The Lancet, 1987
openaire   +2 more sources